Case report: Klinefelter syndrome may protect against the development of spinal and bulbar muscular atrophy

被引:0
|
作者
Akanuma, Haruna [1 ]
Kadowaki, Suguru [2 ]
Kanai, Kazuaki [1 ]
机构
[1] Fukushima Med Univ, Sch Med, Dept Neurol, Fukushima, Japan
[2] Ohta Gen Hosp Fdn, Ohta Nishinouchi Hosp, Dept Neurol, Koriyama, Japan
来源
FRONTIERS IN NEUROLOGY | 2024年 / 15卷
关键词
testosterone; spinal and bulbar muscular atrophy; Klinefelter syndrome; androgen replacement therapy; leuprorelin; EXPRESSION; DISEASE;
D O I
10.3389/fneur.2024.1340694
中图分类号
R74 [神经病学与精神病学];
学科分类号
摘要
Spinal and bulbar muscular atrophy (SBMA) is an X-linked recessive motor neuron disease caused by the expansion of cytosine-adenine-guanine (CAG) repeats in the androgen receptor (AR) gene. It is thought that the nuclear translocation of abnormal AR proteins following binding to testosterone triggers the onset of the disease. We report the case of a patient who had SBMA coincident with Klinefelter syndrome. He developed SBMA symptoms rapidly after receiving androgen replacement therapy for Klinefelter syndrome. No cases of coincident SBMA and Klinefelter syndrome have been reported, and if confirmed by further patients in future, that androgen hormones are strongly associated with the development and progression of SBMA in fact in humans.
引用
收藏
页数:5
相关论文
共 50 条
  • [1] Spinal and Bulbar Muscular Atrophy Overview
    Fischbeck, Kenneth H.
    JOURNAL OF MOLECULAR NEUROSCIENCE, 2016, 58 (03) : 317 - 320
  • [2] Spinal and Bulbar Muscular Atrophy
    Grunseich, Christopher
    Fischbeck, Kenneth H.
    NEUROLOGIC CLINICS, 2015, 33 (04) : 847 - +
  • [3] No evidence of cardiomyopathy in spinal and bulbar muscular atrophy
    Querin, G.
    Melacini, P.
    D'Ascenzo, C.
    Morandi, L.
    Mazzini, L.
    Silani, V.
    Romito, S.
    Mandrioli, J.
    Raimondi, M.
    Pegoraro, E.
    Soraru', G.
    ACTA NEUROLOGICA SCANDINAVICA, 2013, 128 (06): : E30 - E32
  • [4] Developing treatment for spinal and bulbar muscular atrophy
    Fischbeck, Kenneth H.
    PROGRESS IN NEUROBIOLOGY, 2012, 99 (03) : 257 - 261
  • [5] Clinical features of spinal and bulbar muscular atrophy
    Rhodes, Lindsay E.
    Freeman, Brandi K.
    Auh, Sungyoung
    Kokkinis, Angela D.
    La Pean, Alison
    Chen, Cheunju
    Lehky, Tanya J.
    Shrader, Joseph A.
    Levy, Ellen W.
    Harris-Love, Michael
    Di Prospero, Nicholas A.
    Fischbeck, Kenneth H.
    BRAIN, 2009, 132 : 3242 - 3251
  • [6] Longitudinal changes of outcome measures in spinal and bulbar muscular atrophy
    Hashizume, Atsushi
    Katsuno, Masahisa
    Banno, Haruhiko
    Suzuki, Keisuke
    Suga, Noriaki
    Mano, Tomoo
    Atsuta, Naoki
    Oe, Hiroaki
    Watanabe, Hirohisa
    Tanaka, Fumiaki
    Sobue, Gen
    BRAIN, 2012, 135 : 2838 - 2848
  • [7] Dutasteride for spinal and bulbar muscular atrophy
    Banno, Haruhiko
    Katsuno, Masahisa
    Suzuki, Keisuke
    Sobue, Gen
    LANCET NEUROLOGY, 2011, 10 (02) : 113 - 115
  • [8] Progress toward the development of treatment of spinal and bulbar muscular atrophy
    Sahashi, Kentaro
    Hashizume, Atsushi
    Sobue, Gen
    Katsuno, Masahisa
    EXPERT OPINION ON ORPHAN DRUGS, 2017, 5 (06): : 503 - 514
  • [9] Development of a functional composite for the evaluation of spinal and bulbar muscular atrophy
    Inagaki, Tomonori
    Hashizume, Atsushi
    Hijikata, Yasuhiro
    Yamada, Shinichiro
    Ito, Daisuke
    Kishimoto, Yoshiyuki
    Torii, Ryota
    Sato, Hiroyuki
    Hirakawa, Akihiro
    Katsuno, Masahisa
    SCIENTIFIC REPORTS, 2022, 12 (01)
  • [10] Swallowing markers in spinal and bulbar muscular atrophy
    Banno, Haruhiko
    Katsuno, Masahisa
    Suzuki, Keisuke
    Tanaka, Seiya
    Suga, Noriaki
    Hashizume, Atsushi
    Mano, Tomoo
    Araki, Amane
    Watanabe, Hirohisa
    Fujimoto, Yasushi
    Yamamoto, Masahiko
    Sobue, Gen
    ANNALS OF CLINICAL AND TRANSLATIONAL NEUROLOGY, 2017, 4 (08): : 534 - 543